Abstracts tagged "Reproductive Health"

Abstract Number: 0635 • ACR Convergence 2021
Correlation Between Provider Documentation and Patient Experience with Contraceptive Counseling in an Academic Rheumatology Practice
Guiset Carvajal Bedoya¹, Tara Skorupa², Kristin Sturm², Ju Young Kwag², Kristen Demoruelle³ and JoAnn Zell³, ¹University of Colorado, aurora, CO, ²University of Colorado, Denver, CO, ³University of Colorado Anschutz Medical Campus, Aurora, CO
Background/Purpose: In a prior survey of providers and patients (Chakravarty 2014), it became apparent that clear gaps exist in provider-patient communication, affecting the delivery and…
Abstract Number: 1714 • ACR Convergence 2021
Exploring the Sexual and Reproductive Health (SRH) Needs of Men with Rheumatic Diseases
Olivia Stransky¹, Nicole Hunt², John Richards³ and Mehret Birru Talabi¹, ¹University of Pittsburgh, Pittsburgh, PA, ²UPMC, Pittsburgh, PA, ³Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA
Background/Purpose: Few studies have comprehensively evaluated the information needs and priorities that men with rheumatic diseases have about their sexual and reproductive health (SRH). This…
Abstract Number: 1715 • ACR Convergence 2021
Providing High Quality Family Care Planning for Women with Rheumatic Disease in Rheumatology Clinics: Perspectives of Rheumatology Clinicians
Daiva Mitchell¹, Leslie Lesoon¹, Cuoghi Edens², Traci Kazmerski³, Olivia Stransky⁴, Megan Clowse⁵, Sonya Borrero⁴ and Mehret Birru Talabi⁴, ¹UPMC, Pittsburgh, PA, ²University of Chicago, Chicago, IL, ³Children's Hospital of Pittsburgh, Pittsburgh, PA, ⁴University of Pittsburgh, Pittsburgh, PA, ⁵Duke University, Chapel Hill, NC
Background/Purpose: While rheumatologists in several descriptive studies have acknowledged the importance of family planning in their care of women with rheumatic diseases, they have also…
Abstract Number: 1731 • ACR Convergence 2021
Construction and Validation of a Reproductive Health Questionnaire for Women with Rheumatic Diseases
Abraham Yair Lujano-Negrete¹, Luz Ferandanda Gutierrez-Leal², Luis Gerardo Espinosa-Banuelos³, Cassandra Michele Skinner-Taylor¹, Lorena Perez-Barbosa⁴, Ingris Peláez-Ballestas⁵, Eugenio Salvador Barriga-Maldonado⁶, Martha Cecilia Rodriguez-Ruiz¹, Sofía Jezzini-Martínez¹, Selene Maribel Delgado-Ayala¹, Jesus Cardenas-de La Garza⁴ and Dionicio Galarza-Delgado⁴, ¹Hospital Universitario Dr. José Eleuterio González, Monterrey, Mexico, ²Universidad Autónoma de Nuevo León, Monterrey, Mexico, ³Faculty of Medicine and University Hospital Dr. Jose Eleuterio Gonzalez, UANL, Monterrey, Mexico, ⁴Hospital Universitario "Dr Jose E. Gonzalez", Monterrey, Mexico, ⁵Hospital General de Mexico "Dr. Eduardo Liceaga", Mexico, Mexico, ⁶Hopsital Universitario Dr. José Eleuterio González, Monterrey, Mexico
Background/Purpose: Autoimmune rheumatic diseases (ARDs) commonly affect women of childbearing age. Active maternal disease in the months prior to conception increases the risk of flares…
Abstract Number: 129 • 2020 Pediatric Rheumatology Symposium
Reproductive Health Concerns in Young Adults with Pediatric Onset Rheumatic Diseases
Brittany Huynh¹ and Cuoghi Edens ², ¹Indiana University School of Medicine Pediatric Residency, Fishers, ²University of Chicago, Chicago
Background/Purpose: While patients and families of those with pediatric onset rheumatic diseases have keen interest and unaddressed worry about the impact of their rheumatic disease…
Abstract Number: 1853 • 2019 ACR/ARP Annual Meeting
Racial Differences in Highly Effective Contraceptive Use Among Medicaid Beneficiaries with SLE
Jessica Williams¹, Chang Xu ¹, Karen Costenbader ¹, Bonnie Bermas ², Lydia Pace ³ and Candace Feldman ³, ¹Brigham and Women's Hospital, Boston, MA, ²UT Southwestern, Dallas, ³Brigham and Women's Hospital, Boston
Background/Purpose: Highly effective contraception (HEC), which includes intrauterine devices, implants and sterilization, is safe for women with SLE and has a < 1% failure rate…
Abstract Number: 2239 • 2019 ACR/ARP Annual Meeting
Reproductive Health Awareness and Needs: Assessment of Parents, Female Adolescents, and Young Adults with Pediatric Rheumatic Diseases
Veronica Mruk¹, Kristine Carandang ², Megan Clowse ³, Stacy Ardoin ⁴, Elise Berlan ⁵ and Cuoghi Edens ⁶, ¹Nationwide Children's Hospital / The Ohio State University, Columbus, OH, ²University of California/Child and Adolescent Services Research Center, San Diego, CA, ³Duke University, Durham, ⁴Nationwide Children's Hospital/ The Ohio State University, Columbus, OH, ⁵Nationwide Children's Hosptial / The Ohio State University, Columbus, OH, ⁶University of Chicago, Chicago, IL
Background/Purpose: The diagnosis of a pediatric rheumatic disease comes with worries for both parents and patient; one that may be overlooked is the impact on…
Abstract Number: 2274 • 2019 ACR/ARP Annual Meeting
Targeted Education Improves Awareness of Reproductive Health Issues Among Women with Rheumatologic Diseases
Sonya Selvaraj¹, Tanya Allawh ², Meagan Clark ¹, Sneha Patel ³, Christina Payne ⁴ and Arundathi Jayatilleke ¹, ¹Drexel, Philadelphia, PA, ²Hahnemann, Philadelphia, PA, ³Einstein Montefiore, Bronx, NY, ⁴Allegheny General, Philadelphia, PA
Background/Purpose: Managing rheumatologic conditions in women of childbearing age necessitates consideration of reproductive health issues. We studied reproductive health awareness in women with rheumatic disease…
Abstract Number: 2280 • 2019 ACR/ARP Annual Meeting
Reproductive Health Intention Screening in Women with Systemic Rheumatic Diseases: Low Uptake and Gender-Specific Provider Patterns Following a Standardized Intervention
Katherine Pryor¹, Bill Albert ², Susan Ritter ³, Laura Tarter ³, Jonathan Coblyn ³, Bonnie Bermas ⁴, Caryn Dutton ³, Lydia Pace ³, Elizabeth Janiak ³ and Candace Feldman ⁵, ¹Brigham and Women's Hospital, Brookline, ²Power to Decide, Washington, DC, ³Brigham and Women's Hospital, Boston, ⁴UT Southwestern, Dallas, ⁵Brigham and Women's Hospital, Boston, MA
Background/Purpose: Reproductive health intention screening is critical in women with systemic rheumatic diseases, as both disease activity and medication use can impact pregnancy outcomes. However,…
Abstract Number: 2282 • 2019 ACR/ARP Annual Meeting
Reproductive Counseling Documentation Practices for Women Receiving Teratogenic Medications in an Academic Rheumatology Clinic Serving a Medicaid/Medicare Patient Population
Kimberly Showalter¹, Melanie Smith ², Jonathan Cheah ², Nilasha Ghosh ², Elena Gkrouzman ², Sarah Lieber ², Sebastian Sattui ², Noa Schwartz ², Monica Schwartzman ², Jessica Berman ², Lisa Sammaritano ² and Anne Bass ³, ¹Hospital for Special Surgery, New York, NY, ²Hospital for Special Surgery, New York, ³Hospital for Special Surgery/Weill Cornell Medicine, New York, NY
Background/Purpose: Women of reproductive age with rheumatic diseases are often prescribed teratogenic medications; thus, reproductive counseling is important. A prior study demonstrated improvement in counseling…
Abstract Number: 2295 • 2019 ACR/ARP Annual Meeting
Burden of Systemic Lupus Erythematosus Among Korean Women in Childbearing Years Based on the National Health Insurance Service Data
Min Kyung Chung ¹, Jin Su Park ², Hyun Sun Lim ², Chan Hee Lee ² and Jisoo Lee¹, ¹Division of Rheumatology, Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Republic of Korea, ²Division of Rheumatology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea
Background/Purpose: Most women with systemic lupus erythematosus (SLE) are diagnosed with the disease in their reproductive ages, but the burden of SLE among women in…
Abstract Number: 2412 • 2018 ACR/ARHP Annual Meeting
Evaluating Gaps in Reproductive Health Knowledge Among Women with Rheumatic Diseases
Mehret Birru Talabi¹, Megan E. B. Clowse², Susan J. Blalock³, Lan Yu⁴, Alaina Chodoff⁵ and Sonya Borrero⁴, ¹Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, ²Department of Medicine, Division of Rheumatology and Immunology, Duke University, Durham, NC, ³Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, ⁴Medicine, University of Pittsburgh, Pittsburgh, PA, ⁵General Internal Medicine, UPMC, Pittsburgh, PA
Background/Purpose: While women with rheumatic diseases may face considerable reproductive health challenges, few studies have objectively assessed what these women know about their reproductive risks.…
Abstract Number: 2419 • 2018 ACR/ARHP Annual Meeting
Needs Assessment and Implementation of a Reproductive Health Intention Screen for Women with Systemic Rheumatic Diseases
Elizabeth Janiak¹, Latoya Bartlett², Joy Gulla², Bill Albert³, Sonali Desai⁴, Susan Ritter⁵, Laura Tarter⁵, Jonathan Coblyn⁵, Bonnie L. Bermas⁶, Wan-Ju Wu¹, Caryn Dutton¹, Lydia Pace⁷ and Candace H. Feldman⁴, ¹Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, ²Brigham and Women's Hospital, Boston, MA, ³Power to Decide, Washington, DC, DC, ⁴Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ⁵Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ⁶Rheumatology, University of Texas, Southwestern, Dallas, TX, ⁷Division of Women's Health, Brigham and Women's Hospital, Boston, MA
Background/Purpose: Among women with systemic rheumatic diseases (SRD), poor maternal and fetal outcomes may occur if disease activity and medication use are not optimized preconception.…
Abstract Number: 2421 • 2018 ACR/ARHP Annual Meeting
Pregnancy Outcomes in Women with Rheumatic Diseases and Thrombophilia Treated in a Multidisciplinary Unit
Isabel Añón Oñate¹, Irene Notario¹, Miguel Ángel Ferrer¹, Lorena Pérez¹, María Ramírez¹ and Rafael Cáliz², ¹Rheumatology, Hospital Universitario Virgen de las Nieves, Granada, Spain, ²Hospital Universitario Virgen de las Nieves, Granada, Spain
Background/Purpose: To evaluate the efficacy of the treatment on the pregnancy outcomes of women with Rheumatic Diseases and Thrombophilia from a Spanish cohort. Their pregnancies…
Abstract Number: 2439 • 2018 ACR/ARHP Annual Meeting
A Description of Contraception Practices in the Ohio State University Lupus Cohort
Veronica Mruk¹, Ashlee Weaver², Alexa Zofia³, Emily Sullivan⁴, Kelly Morris⁵, Stacy P. Ardoin⁶, Elise Berlan⁷ and Alexa Meara⁸, ¹The Nationwide Children's Hospital, Columbus, OH, ²The Ohio State University School of Medicine, Columbus, OH, ³The Ohio State University, Columbus, OH, ⁴The Ohio State Univeristy Wexner Medical Center, Columbus, OH, ⁵Rheumatology and Immunology, The Ohio State University, Columbus, OH, ⁶The Ohio State University Wexner Medical Center, Columbus, OH, ⁷Adolescent Medicine, Nationwide Children's Hospital, columbus, OH, ⁸Internal Medicine/Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH
Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease, which predominantly affects women and reaches peak incidence during reproductive years. Periods of high…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].